Results 41 to 50 of about 4,982,676 (293)

Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy

open access: yesFrontiers in Immunology, 2019
Tolerogenic dendritic cells and T-regulatory cells are two immune cell populations with the potential to prevent the onset of clinical stage type 1 diabetes, and manage the beginning of underlying autoimmunity, at the time-at-onset and onwards.
Brett Eugene Phillips   +6 more
doaj   +1 more source

Tolerogenic and Activatory Plasmacytoid Dendritic Cells in Autoimmunity [PDF]

open access: yesFrontiers in Immunology, 2013
Plasmacytoid dendritic cells (pDCs) are a particular subset of DCs that link innate and adaptive immunity. They are responsible for the substantial production of type 1 interferon (IFN-I) in response to viral RNA or DNA through activation of TLR7 and 9. Furthermore, pDCs present antigens (Ag) and induce naïve T cell differentiation.
Guéry L, Hugues S.
openaire   +5 more sources

Dendritic cells in experimental renal inflammation - Part I [PDF]

open access: yes, 2011
Dendritic cells (DCs) are bone marrow-derived professional antigen-presenting cells that act as master regulators of acquired and innate immune responses.
Elfriede Noessner   +15 more
core   +1 more source

Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution

open access: yesNature Communications, 2021
Nasopharyngeal carcinoma is a diverse cancer characterised by a heterogeneous microenvironment. Here, the authors use single cell sequencing to analyse the tumour microenvironment in 10 nasopharyngeal carcinoma tumours and identify different cell types ...
Yang Liu   +20 more
doaj   +1 more source

Fludarabine disrupts the STAT1/AhR interaction to attenuate type 1 diabetes by inducing tolerogenic dendritic cells along with targeting effector T cells. [PDF]

open access: goldMol Med
Rong SJ   +22 more
europepmc   +2 more sources

Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications [PDF]

open access: yesImmune Network, 2016
Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that bridge innate and adaptive immune responses, thereby leading to immune activation. DCs have been known to recognize pathogen-associated molecular patterns such as lipopolysaccharides (LPS) and nucleic acids via their pattern recognition receptors, which trigger signaling of ...
Yoo, Seungbo, Ha, Sang-Jun
openaire   +2 more sources

The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells via miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin/IL10 Axis

open access: yesFrontiers in Immunology, 2018
By shaping T cell immunity, tolerogenic dendritic cells (tDCs) play critical roles in the induction of immune tolerance after transplantation. However, the role of long noncoding RNAs (lncRNAs) in the function and immune tolerance of dendritic cells (DCs)
Jian Wu   +26 more
doaj   +1 more source

Interferon-α abrogates tolerance induction by human tolerogenic dendritic cells. [PDF]

open access: yesPLoS ONE, 2011
BACKGROUND: Administration of interferon-α (IFN-α) represents an approved adjuvant therapy as reported for malignancies like melanoma and several viral infections.
Nicole Bacher   +4 more
doaj   +1 more source

Sitagliptin Induces Tolerogenic Human Dendritic Cells

open access: yesInternational Journal of Molecular Sciences, 2023
Sitagliptin, an anti-diabetic drug, is a dipeptidyl peptidase (DPP)-4/CD26 inhibitor with additional anti-inflammatory and immunomodulatory properties. In this study, we investigated for the first time the effect of sitagliptin on the differentiation and functions of human dendritic cells generated from monocytes (MoDCs) for 4 days using the standard ...
Marija Drakul   +9 more
openaire   +3 more sources

A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells [PDF]

open access: yes, 2007
Viral mutational escape can reduce or abrogate recognition by the T cell receptor (TCR) of virus-specific CD8+ T cells. However, very little is known about the impact of cytotoxic T lymphocyte (CTL) epitope mutations on interactions between peptide–major
Feeney, M   +56 more
core   +1 more source

Home - About - Disclaimer - Privacy